You have 9 free searches left this month | for more free features.

tofacitinib

Showing 26 - 50 of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

Active, not recruiting
  • Neoplasms With Mesothelin Expression
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2022

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 7, 2022

ive Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept

Completed
  • Rheumatoid Arthritis
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

Recruiting
  • Rheumatic Arthritis
  • Tofacitinib
  • Etanercept
  • Berlin, Germany
  • +5 more
Mar 1, 2022

ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)

Completed
  • ANCA Associated Vasculitis
  • +2 more
  • Tofacitinib
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 20, 2021

Granulomatosis With Polyangiitis Trial in Shanghai (Tofacitinib, Methotrexate)

Recruiting
  • Granulomatosis With Polyangiitis
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 5, 2021

Rheumatoid Arthritis Trial in Hangzhou (Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Tofacitinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 9, 2021

Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)

Recruiting
  • Idiopathic Inflammatory Myopathies
  • tofacitinib
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Oct 9, 2022

Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Tofacitinib, Pred)

Recruiting
  • Arthritis, Rheumatoid
  • Jinan, Shandong, China
    Qilu Hospital
Jun 17, 2021

Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • London, Ontario, Canada
    Rheumatology Clinic, St. Joseph's Health Care
May 10, 2022

COVID-19 Trial in Moscow (Tofacitinib)

Completed
  • COVID-19
  • Tofacitinib
  • Moscow, Russian Federation
    Sechenov First Moscow State Medical University (Sechenov Univers
Feb 11, 2021

Uveitis, Scleritis Trial in Saint Louis (tofacitinib)

Unknown status
  • Uveitis
  • Scleritis
  • tofacitinib
  • Saint Louis, Missouri
    Washington University in Saint Louis
Jan 7, 2021

Healthy Trial in Merksem (JNJ-64251330, Tofacitinib)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Dec 30, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Dermatomyositis Trial in Baltimore (Tofacitinib)

Completed
  • Dermatomyositis
  • Tofacitinib
  • Baltimore, Maryland
    Johns Hopkins University
Nov 5, 2020

Healthy Trial in Merksem (Tofacitinib)

Completed
  • Healthy
  • Tofacitinib
  • Merksem, Belgium
    Clinical Pharmacology Unit
Oct 26, 2021

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Rheumatoid Arthritis Trial in Seoul (Tofacitinib)

Unknown status
  • Rheumatoid Arthritis
  • Tofacitinib
  • Seoul, Korea, Republic of
    Hanyang University
Jun 23, 2020

Juvenile Idiopathic Arthritis Trial in Worldwide (Tofacitinib)

Recruiting
  • Juvenile Idiopathic Arthritis
  • Tofacitinib
  • Phoenix, Arizona
  • +134 more
Jan 25, 2023

Rheumatoid Arthritis Trial in Dhaka (Methotrexate, Tofacitinib)

Unknown status
  • Rheumatoid Arthritis
  • Dhaka, Bangladesh
    Bangabandhu Seikh Mujib Medical University
Jul 6, 2020

Ulcerative Colitis Trial in Worldwide (tofacitinib)

Recruiting
  • Ulcerative Colitis
  • tofacitinib
  • Phoenix, Arizona
  • +92 more
Jan 25, 2023

COVID-19 Trial in United States (Tofacitinib, Placebo)

Withdrawn
  • COVID-19
  • Tofacitinib
  • Placebo
  • Hartford, Connecticut
  • +5 more
Jul 29, 2020

Systemic Sclerosis, Scleroderma Trial in Ann Arbor, Pittsburgh (Tofacitinib, Placebo Oral Tablet)

Completed
  • Systemic Sclerosis
  • Scleroderma
  • Tofacitinib
  • Placebo Oral Tablet
  • Ann Arbor, Michigan
  • +1 more
Apr 28, 2020

SARS-COv2 Related Interstitial Pneumonia Trial in Ancona (Tofacitinib)

Unknown status
  • SARS-COv2 Related Interstitial Pneumonia
  • Tofacitinib
  • Ancona, Marche, Italy
    Ospedali Riuniti di Ancona
Apr 1, 2020